Sudeep Pharma IPO: Analysis and Forecast

Key Points

• Strong investor demand drove the Sudeep Pharma IPO oversubscription.
• Qualified Institutional Buyers (QIBs) heavily invested, exceeding quota.
• Retail and non-institutional investors also showed significant interest.
• Anchor investors contributed ₹268.5 crore before the IPO launch.
• Grey market trends suggest a potential listing near ₹691.
• Grey market data is unreliable; actual listing performance uncertain.

Sudeep Pharma, a company making ingredients for medicines, is scheduled to start trading on November 28, 2025. The grey market – where shares trade before they’re officially listed – is already showing a positive sign, predicting a strong opening for the company’s shares. The IPO itself raised ₹895 crore through a combination of new shares and selling existing shares.

IPO Details

The IPO involved offering 1.6 million new shares worth ₹95 crore and 13.5 million existing shares worth ₹800 crore. The price for these shares was between ₹563 and ₹593. Investors had from November 21 to November 25, 2025, to buy them. MUFG Intime India is handling the registration process, and ICICI Securities and IIFL Capital Services are managing the offering.

Anchor Investor Participation

Before the IPO opened, Sudeep Pharma secured ₹268.5 crore from a group of important investors. This money was raised by selling 4.52 million shares at a price of ₹593 each. Investors involved included major mutual funds like SBI, HDFC, and ICICI Prudential, along with others like Nippon India and WhiteOak Capital. This early investment signaled high confidence in the company.

Grey Market Prediction

Unlisted shares of Sudeep Pharma were trading at approximately ₹690.5 per share in the grey market on November 26, 2025. This represents a premium of ₹97.5 or 16.44% compared to the IPO’s issue price of ₹593. If these grey market trends continue, the shares could list around ₹691, which would be a gain of roughly 16.5% for investors who bought them in the IPO. However, experts caution that the grey market isn’t a reliable indicator of how the stock will perform on the actual stock exchange.

“The grey market provides a potential glimpse, but doesn’t guarantee the final listing price.”